Our study suggests that they might play similar roles in lung cancer metastasis, as the majority of ADC patients with poor prognosis had high JNK1 and CHK1 expression levels, whereas most ADC patients with good prognosis had low CHK1 expression. This evidence concerns the gene MAPK8 and lung cancer.